(Q35546875)

8 August 2017

title

Limited effect of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial (English)

1 reference

8 August 2017

0 references

Egsmose C

1

1 reference

8 August 2017

Hansen TM

2

1 reference

8 August 2017

Andersen LS

3

1 reference

8 August 2017

Beier JM

4

1 reference

8 August 2017

Christensen L

5

1 reference

8 August 2017

Ejstrup L

6

1 reference

8 August 2017

Peters ND

7

1 reference

8 August 2017

van der Heijde DM

8

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

Annals of the Rheumatic Diseases

8 August 2017

published in

1 reference

8 August 2017

volume

56

1 reference

8 August 2017

issue

1

1 reference

8 August 2017

page(s)

32-36

1 reference

Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752243

Sulphasalazine: a 'new' antirheumatic drug

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752243

Repeat ileocolonoscopy in reactive arthritis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752243

Therapy of seronegative oligoarthritis with salazopyrine

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752243

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752243

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752243

Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752243

Evaluation of sulphasalazine in the treatment of spondyloarthropathies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752243

Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752243

Sulphasalazine in rheumatoid arthritis

26 September 2018

1 reference

12 December 2020

Reiter's syndrome. Evaluation of preliminary criteria for definite disease

1 reference

12 December 2020

1 reference

12 December 2020

Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.56.1.32

1 reference

8 August 2017

1 reference

8 August 2017

1 reference